DECA-DURABOLIN Drug Patent Profile
✉ Email this page to a colleague
When do Deca-durabolin patents expire, and when can generic versions of Deca-durabolin launch?
Deca-durabolin is a drug marketed by Woodward Specl and is included in one NDA.
The generic ingredient in DECA-DURABOLIN is nandrolone decanoate. There are fifteen drug master file entries for this compound. Additional details are available on the nandrolone decanoate profile page.
Summary for DECA-DURABOLIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 15 |
Clinical Trials: | 2 |
Patent Applications: | 5 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DECA-DURABOLIN at DailyMed |
Recent Clinical Trials for DECA-DURABOLIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Morten Tange Kristensen PT, PhD | Phase 2 |
University Hospital Ostrava | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for DECA-DURABOLIN
US Patents and Regulatory Information for DECA-DURABOLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Woodward Specl | DECA-DURABOLIN | nandrolone decanoate | INJECTABLE;INJECTION | 013132-001 | Jun 12, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Woodward Specl | DECA-DURABOLIN | nandrolone decanoate | INJECTABLE;INJECTION | 013132-002 | Jun 12, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Woodward Specl | DECA-DURABOLIN | nandrolone decanoate | INJECTABLE;INJECTION | 013132-003 | Jun 12, 1986 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |